- トップ
- 研究業績
- Hattori K, Sakata-Yanagimoto M, Okoshi Y, Goshima Y, Yanagimoto S, Nakamoto-Matsubara R, Sato T, Noguchi M, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Chiba S. MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma. Br J Haematol May 10, 2016 (doi: 10.1111/bjh.14080. ) [Epub ahead of print]
Hattori K, Sakata-Yanagimoto M, Okoshi Y, Goshima Y, Yanagimoto S, Nakamoto-Matsubara R, Sato T, Noguchi M, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Chiba S. MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma. Br J Haematol May 10, 2016 (doi: 10.1111/bjh.14080. ) [Epub ahead of print]
2016/11/11
- 研究業績
- Hattori K, Sakata-Yanagimoto M, Okoshi Y, Goshima Y, Yanagimoto S, Nakamoto-Matsubara R, Sato T, Noguchi M, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Chiba S. MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma. Br J Haematol May 10, 2016 (doi: 10.1111/bjh.14080. ) [Epub ahead of print]
« Nagao R, Kikuti YY, Carreras J, Kikuchi T, Miyaoka M, Matsushita H, K... | 千葉 滋：骨髄系腫瘍とリンパ系腫瘍におけるTET2変異の意義 臨床血液57（6）：715-722 »
